IM Cannabis Corp. Form 6-K Summary
Business context and reporting period
IM Cannabis Corp., an Israel-based foreign private issuer, filed this Form 6-K on November 24, 2021. The filing furnishes interim consolidated financial statements and management’s discussion and analysis for the three and six months ended September 30, 2021.
The filing incorporates Exhibits 99.1 and 99.2 by reference into the company’s Form F-10 registration statement. The provided text contains the Form 6-K cover page and exhibit index, but not the underlying financial statements or MD&A.
Financial metrics
- Revenue, profit or loss, cash flow, margins, debt, liquidity, and other financial metrics: the filing text provided does not include clear values.
- Management’s discussion of operating performance and financial condition: not included in the provided text.
Material changes versus the prior comparable period
The provided filing text does not describe changes versus the prior-year or prior-period comparable results.
Guidance, outlook, risks, contingencies, and unusual items
No guidance, outlook, risk factors, contingencies, or unusual items are described in the provided cover-page text. These matters may be addressed in Exhibits 99.1 and 99.2, which were listed but not supplied.
Important facts to verify
- Review Exhibit 99.1 for the complete interim consolidated financial statements for the three and six months ended September 30, 2021.
- Review Exhibit 99.2 for revenue trends, profitability, cash flows, liquidity, debt, segment information, and management commentary.
- Confirm all comparative-period figures, non-GAAP measures, accounting policies, and going-concern or liquidity disclosures in the full exhibits.
- Note that the Form 6-K was filed in November 2021, while the reported financial periods ended September 30, 2021.